Gauthier George 4
4 · IGM Biosciences, Inc. · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Gauthier George
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-10-02$7.95/sh−935$7,430→ 39,082 total
Footnotes (2)
- [F1]The sale reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan, entered into on December 29, 2022, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- [F2]This transaction was executed in multiple trades at prices ranging from $7.80 to $8.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.